Clinical Trials · NCT01679080
The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- University of Aarhus
- Enrollment
- 9
- Start date
- Nov 2012
- Locations
- 3 sites, Denmark
- Primary endpoint
- Bone Mineral Density (BMD)